Alzheimer's Disease clinical trials
Showing 101–150 of 331 active trials. Describe your situation to see which ones you may be eligible for.
- Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Preventing Alzheimer's With Cognitive Training
- Exercise to Improve Brain Health in Older African Americans
- Combating Alzheimer's Through Sleep and Exercise
- Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's Disease
- Sleep Trial to Prevent Alzheimer's Disease
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
- Natives Engaged in Alzheimers Research - 'Ike Kupuna
- Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Promoting Physical Activity in Older Hispanic/Latino(a) Adults
- Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
- PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
- A Study of AMDX-2011P in Participants With Alzheimer's Disease
- MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
- Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- Assess Fibrin in Brains With AD/ADRD
- UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
- [18F]PI-2620 Phase 3 Histopathological Study
- Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
- UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
- Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
- Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- PET Tau - Neurodegenerative Disease Imaging
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- A Study of LY3439539 in Participants With Alzheimer's Disease
- A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Predicting Pre-dementia
- A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
- Phosphorylated Tau Levels in Donated Blood
- Brain NAD in Alzheimer's Disease
- Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
- A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
- Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
- Speech Pattern Evaluation and Analysis for Knowledge of AD
- Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
- Triage Survey for Neurology Research Eligibility
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.